Literature DB >> 24892959

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane.

Suzan Commandeur1, Sarah J Sparks, Hee-Lam Chan, Linda Gao, Jacoba J Out, Nelleke A Gruis, Remco van Doorn, Abdoelwaheb El Ghalbzouri.   

Abstract

A critical first step in the metastatic progression of cutaneous melanoma, invasive growth into the dermal compartment, would ideally be studied in the proper three-dimensional tissue microenvironment. In this study, we compared the growth and behavior of four melanoma cell lines originating from primary and metastatic human cutaneous melanomas (AN, RU, M14, and WK) in in-vitro human skin equivalents (HSEs) generated with four different dermal matrices: human fibroblast-seeded rat tail collagen, human fibroblast-derived matrix (FDM), noncellular human de-epidermized dermis (DED), and a novel fully cellular human DED with an intact pre-existent basement membrane. Melanoma cells showed proliferation in all HSEs, indicating that the microenvironment formed in all HSEs studied here allows the growth of melanoma cells in concert with epidermal keratinocytes for multiple weeks in vitro. Melanoma cells did not affect epidermal proliferation and terminal differentiation. Growth of melanoma cells in the dermal compartment, as a measure of invasive potential, differs markedly between the four types of in-vitro human melanoma models. Notably, the growth of melanoma cells in the dermal matrix was observed in all HSEs cultured with cell lines originating from metastatic melanoma, except for cDED-based HSEs, and the growth of melanoma cells of nonmetastatic origin was observed in the dermal compartment of FDM-based HSEs. Our results show that the type of dermal equivalent and the presence of an intact basement membrane should be taken into consideration when studying melanoma invasion using in-vitro HSEs.

Entities:  

Mesh:

Year:  2014        PMID: 24892959     DOI: 10.1097/CMR.0000000000000079

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  3 in total

1.  How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development.

Authors:  Monika Schäfer-Korting; Christian Zoschke
Journal:  Handb Exp Pharmacol       Date:  2021

2.  A preclinical model of cutaneous melanoma based on reconstructed human epidermis.

Authors:  Anna Leikeim; Maximiliane Wußmann; Freia F Schmidt; Nuno G B Neto; Franziska Benz; Kendra Tiltmann; Corinna Junger; Michael G Monaghan; Bastian Schilling; Florian K Groeber-Becker
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

3.  A shift from papillary to reticular fibroblasts enables tumour-stroma interaction and invasion.

Authors:  Marieke Hogervorst; Marion Rietveld; Frank de Gruijl; Abdoelwaheb El Ghalbzouri
Journal:  Br J Cancer       Date:  2018-03-19       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.